Respiratory syncytial virus (RSV) is now a significant problem for certain adult populations, such as older adults, those with cardiopulmonary diseases, and immunocompromised persons. RSV infections in adults often go unrecognized in clinical settings owing to low clinical suspicion, despite growing knowledge of its disease burden. RSV is primarily spread through respiratory droplets, either by direct contact with an infected person or by touching contaminated surfaces. Clinical features, including nasal congestion, cough, wheezing, and low-grade fever, may be difficult to differentiate from those of other respiratory viral infections. As a result, diagnosis of RSV infection in hospitalized adults is often delayed, which can impact clinical management and outcomes. Currently, standard care for managing RSV infection in adults is supportive with oxygen, bronchodilators, intravenous fluids, and antipyretics.
Are you up-to-date on adult RSV and how it might affect your patients? Test yourself with a short quiz.
Medscape © 2024 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Denyse Lutchmansingh. Rapid Review: Adult Respiratory Syncytial Virus - Medscape - Feb 22, 2024.
Comments